Gilead Sciences | GILD - Capitalización De Mercado

Precio De Mercado
129.58
Cambio Diario
-2.48 -1.88%
Mensual
-6.47%
Anual
26.42%
Q2 Expectativa
126.98




Capitalización De Mercado Cambio Fecha
AbbVie USD 364.22B 20.46B 2026-05
Agios Pharmaceuticals USD 2.01B 423M 2026-03
ALKERMES USD 5.66B 217M 2026-05
Alnylam Pharmaceuticals USD 44.15B 8.39B 2026-03
Amgen USD 189.89B 13.64B 2026-03
Biogen USD 26.9B 1.09B 2026-03
BioMarin Pharmaceutical USD 10.18B 683M 2026-05
Bristol-Myers Squibb USD 123.83B 14.02B 2026-03
Coherus Biosciences USD 172M 19M 2025-12
Eli Lilly USD 869.02B 146.97B 2026-03
Gilead Sciences USD 167.39B 5.6B 2026-05
GlaxoSmithKline GBP 83.8B 9.44B 2026-03
Incyte USD 21.73B 3B 2026-05
J&J USD 579.15B 78.91B 2026-03
Merck USD 297.1B 35.84B 2026-03
Moderna USD 20.15B 8.53B 2026-03
Neurocrine Biosciences USD 15.15B 1.9B 2026-05
Novartis USD 232.75B 75B 2026-05
Pfizer USD 147.4B 6.42B 2026-05
PTC Therapeutics USD 4.94B 698M 2026-05
Regeneron Pharmaceuticals USD 81.68B 560M 2026-03
Sanofi EUR 100.27B 605.48M 2026-03
Sarepta Therapeutics USD 2.16B 123M 2026-05
United Therapeutics USD 28.08B 2.9B 2026-05
Vertex Pharmaceuticals USD 113.58B 1000K 2026-05